Sage-N Research signs agreement with the U.S. Army ECBC
7 July 2011 | By The Scott Partnership
Sage-N, entered into an exclusive license agreement with the U.S. Army ECBC to commercialize a revolutionary new platform...
List view / Grid view
News
Novozymes Biopharma to present latest advances in drug delivery technology at Controlled Release Society Meeting
6 July 2011 | By The Scott Partnership
Two new scientific posters to be presented at the 2011 CRS meeting...
Boehringer Ingelheim and Ashoka’s Changemakers launch “Making More Health” competition
6 July 2011 | By Boehringer Ingelheim
The www.changemakers.com/morehealth competition launched...
Wyatt Technology’s Möbius Mobility Instrument Facilitates Protein Net Charge Computation at Low Concentrations
5 July 2011 | By The Scott Partnership
Möbius electrophoretic mobility instrument can measure precise protein charges...
Amgen and UCB team up With NASA
5 July 2011 | By Amgen
Amgen and UCB announced that they are collaborating with the NASA Ames Research Center to conduct a preclinical test...
Positive top-line results for Pfizer’s Lyrica in Phase 3 Study of patients with Fibromyalgia in Japan
5 July 2011 | By Pfizer
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208...
Novartis drug Afinitor® met primary endpoint of Phase III study
5 July 2011 | By Novartis AG
Afinitor® in combination with exemestane extended progression-free survival in women with advanced breast cancer...
London 2012 partner, GlaxoSmithKline, shares scientific expertise with WADA to help fight against abuse of drugs in sport
4 July 2011 | By GlaxoSmithKline
GlaxoSmithKline signed a long-term agreement with the World Anti-Doping Agency...
Pfizer affirms CHANTIX/CHAMPIX as important treatment option for smokers wanting to quit
4 July 2011 | By Pfizer
An effective and appropriate treatment option for adult smokers wanting to quit...
Biogen Idec researchers identify novel approach for promoting Remyelination
3 July 2011 | By Biogen Idec
Results from a study that suggest that inhibiting death receptor-6 (DR6) function may represent a novel approach...
Lilly Quality Leader Walsh appointed to Company’s Executive Committee
1 July 2011 | By Eli Lilly and Company
Fionnuala Walsh, Ph.D., will join the executive committee of Eli Lilly and Company on July 1...
Lundbeck appoints Senior Vice President of HR
1 July 2011 | By H. Lundbeck A/S
H. Lundbeck A/S has appointed Teddy Hebo Larsen as Senior Vice President of HR...
Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)
1 July 2011 | By Novartis
Novartis announced that the US FDA approved once-daily Arcapta(TM) Neohaler(TM) (indacaterol inhalation powder)...
Merck statement on voluntary submission of clinical research protocols
1 July 2011 | By Merck
For its investigational and approved products...
GlaxoSmithKline receives new approval for Rotarix and significant new indication for Lamictal® (lamotrigine) in Japan
1 July 2011 | By GlaxoSmithKline
GSK announced that its rotavirus vaccine has received approval in Japan...
